Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-01-22

Clinical Trial Update: Assess the Effect of Erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether erythromycin improves the success rate of self-propelled feeding tube placement in pancreatitis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERYTHROMYCIN (ERYTHROMYCIN)

Snippet

Sponsor: Canisius-Wilhelmina Hospital | Conditions: Pancreatitis | Phase 4 | Status: COMPLETED